FORMULARY DECISION
Bimekizumab : Bimzelx
SMC2410 : Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. SMC restriction: for patients who have failed to respond to standard systemic therapies (i...
We have found 21 results when searching "Bimekizumab"
SMC2410 : Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. SMC restriction: for patients who have failed to respond to standard systemic therapies (i...